|
⚲
|
| Keyboard |
| B Capital Group Management LP
✚
|
|
|---|---|
| CRD # | 287986 |
| SEC # | 802-110185 |
| CIK # | 0001997306 |
| AUM | |
| Employees | |
| Phone | |
| Address | 1240 Rosecrans Ave Manhattan Beach, CA 90266 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] [Instagram] |
| Total AUM ($) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | B Capital Coinvest Fund N2 LP | 2025-03-31 | 150.0 M | |
| VC | B Capital Global Growth IV LP | [2025-03-31] | 1,089.2 M | |
| Filed 2024-07-09 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | B Capital Healthcare II LP | [2025-03-31] | 86.5 M | |
| Filed 2024-07-09 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | B Capital Resilience Tech I LP | [2025-03-31] | 27.3 M | |
| Filed 2024-07-09 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | B Capital Ascent Fund III LP | [2024-03-28] | 307.3 M | 441.2 M |
| Filed 2025-07-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | B Capital Mesa Venture Fund I LP | [2024-03-28] | 101.6 M | 100.7 M |
| Filed 2025-07-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | B Capital Coinvest Fund N LP | 2023-03-31 | 364.9 M | |
| VC | B Capital Growth Coinvest Fund K2 LP | 2023-03-31 | 129.2 M | |
| VC | B Capital Opportunities Fund II LP | [2023-03-31] | 754.1 M | 812.7 M |
| Offered $754,082,500 · Filed 2024-03-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Commission $200,000 · Revenue Decline to Disclose | ||||
| VC | B Capital Ascent Coinvest Fund LP | 2022-03-31 | 23.0 M | |
| VC | B Capital China I LP | [2022-03-31] | 234.7 M | 280.5 M |
| Offered $234,715,736 · Filed 2023-01-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | B Capital Global Growth III LP | [2022-03-31] | 1,588.3 M | 1,917.0 M |
| Offered $1,588,259,000 · Filed 2023-01-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | B Capital Growth Coinvest Fund B LP | 2022-03-31 | 79.4 M | |
| VC | B Capital Growth Coinvest Fund LP | 2022-03-31 | 167.7 M | |
| VC | B Capital Healthcare I LP | [2022-03-31] | 243.9 M | 323.3 M |
| Offered $243,950,000 · Filed 2023-01-19 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | B Capital Ascent Fund II LP | [2021-03-25] | 254.0 M | 348.1 M |
| Offered $254,007,500 · Filed 2022-07-27 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | B Capital Opportunities Fund I LP | [2021-03-25] | 200.0 M | 470.2 M |
| Filed 2020-03-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | B Capital Fund II LP | [2020-03-20] | 821.8 M | 960.4 M |
| Filed 2020-06-30 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $473,250 · Revenue Decline to Disclose | ||||
| VC | B Capital Fund LP | [2017-03-13] | 181.0 M | 460.1 M |
| Filed 2017-05-24 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| B Capital Group Partners II LP | Promoter | 2 | 1 | |
| B Capital Group Partners LP | Promoter | 1 | 1 | |
| B Capital Healthcare GP I LP | Promoter | 1 | 1 | |
| B Capital Global Growth GP IV LP | Promoter | 1 | 1 | |
| B Capital Climate GP I LP | Promoter | 1 | 1 | |
| B Capital Mesa Venture GP I LP | Promoter | 1 | 1 | |
| B Capital Ascent GP II LP | Promoter | 1 | 1 | |
| B Capital China GP I LP | Promoter | 1 | 1 | |
| B Capital Opportunities GP II LP | Promoter | 1 | 1 | |
| B Capital Healthcare GP II LP | Promoter | 1 | 1 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001997306] | |
| 4 | [0001997306] | |
| SC 13G | [0001997306] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| B Capital Group Management LP | Carlsmed Inc | [2025-11-14] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Carlsmed Inc CARL
Common Stock
|
2025-07-24 | Conversion | 931,452 | ||
|
Carlsmed Inc CARL
Common Stock
|
2025-07-24 | Buy | 1,333,333 | $15.00 | 19,999,995 |
|
Carlsmed Inc CARL
Common Stock
|
2025-07-24 | Conversion | 2,376,472 | ||
|
Carlsmed Inc CARL
Common Stock
|
2025-07-24 | Conversion | 3,680,506 | ||
|
Carlsmed Inc CARL
Series B Preferred Stock · derivative
|
2025-07-24 | Conversion | 1,445,020 | ||
|
Carlsmed Inc CARL
Series B Preferred Stock · derivative
|
2025-07-24 | Conversion | 1,445,020 | ||
|
Carlsmed Inc CARL
Series C Preferred Stock · derivative
|
2025-07-24 | Conversion | 931,452 | ||
|
Carlsmed Inc CARL
Series C Preferred Stock · derivative
|
2025-07-24 | Conversion | 931,452 | ||
|
Carlsmed Inc CARL
Series C Preferred Stock · derivative
|
2025-07-24 | Conversion | 2,235,486 |